Once-Yearly Aclasta® Approved In EU To Treat Male Osteoporosis And To Reduce Risk Of New Fractures Following Hip Fracture In Both Sexes

The European Commission has approved once-yearly Aclasta®* (zoledronic acid 5 mg) for the treatment of osteoporosis in men who are at increased risk of fractures.

New Surgical Interference Screw Provides Secure, Versatile, Bioabsorbable Fixation in ACL Repair

Smith & Nephew’s Endoscopy Division has announced the launch of its bioabsorbable BIOSURE™ HA Interference Screw line for use in Anterior Cruciate Ligament (ACL) and Posterior Cruciate Ligament (PCL) reconstruction.

Most read

Latest

^